IPO market

Avience Biomedicals IPO is a SME book building IPO. Issue size is 30 Cr. Price band is ₹196 to ₹208 per share. Minimum investment is ₹2.50 L. Lot size is 600 shares. Open from 18 Jun 2026 to 22 Jun 2026. Allotment on 23 Jun 2026. Listing on 25 Jun 2026 at NSE. Managed by Fintellectual Corporate Advisors Pvt.Ltd. Registrar: Skyline Financial Services Private Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.
Price band, lot, minimum application, and issue window at a glance.
Subscription, allotment, refund, share credit, and listing milestones.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 1,200 | ₹2,49,600 |
| S-HNI (Min) | 3 | 1,800 | ₹3,74,400 |
| S-HNI (UPI) | 4 | 2,400 | ₹4,99,200 |
| S-HNI (Max) | 8 | 4,800 | ₹9,98,400 |
| B-HNI (Min) | 9 | 5,400 | ₹11,23,200 |
From the company / RHP narrative.
How the issuer plans to use IPO proceeds.
Figures from the IPO financial table (₹ Cr). Switch metric to compare years.
Avience Biomedicals IPO
Pre-filled: Issue Price = ₹208, Lot Size = 600 shares, Listing Price = ₹395.2
| Category | Lots | Investment | At listing | Profit |
|---|---|---|---|---|
| Retail (Min) | 2 | ₹2,49,600 | ₹395 | +₹2,24,640 |
| S-HNI (Min) | 3 | ₹3,74,400 | ₹395 | +₹3,36,960 |
| S-HNI (UPI) | 4 | ₹4,99,200 | ₹395 | +₹4,49,280 |
| S-HNI (Max) | 8 | ₹9,98,400 | ₹395 | +₹8,98,560 |
| B-HNI (Min) | 9 | ₹11,23,200 | ₹395 | +₹10,10,880 |
Profit based on the official listing price for each investor category.
A quick overview of key terms, dates, and how to track this IPO.
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Reserved portion of the issue by investor category (break data).